AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 66 filers reported holding AGILE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $141,000 | -11.9% | 67,725 | +28.9% | 0.00% | 0.0% |
Q3 2020 | $160,000 | -10.1% | 52,555 | -18.0% | 0.00% | -33.3% |
Q2 2020 | $178,000 | +85.4% | 64,082 | +24.1% | 0.00% | 0.0% |
Q1 2020 | $96,000 | +540.0% | 51,655 | +1813.1% | 0.00% | +200.0% |
Q4 2016 | $15,000 | – | 2,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 15,919,925 | $15,301,000 | 0.22% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $706,000 | 0.09% |
INVESTOR AB | 3,510,189 | $3,370,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 586,491 | $564,000 | 0.06% |
FIRST MIDWEST BANK TRUST DIVISION | 335,735 | $322,000 | 0.05% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 70,000 | $67,000 | 0.02% |
Summit Global Investments | 126,000 | $121,000 | 0.01% |
Ergoteles LLC | 211,611 | $203,000 | 0.01% |
Centric Wealth Management | 10,000 | $10,000 | 0.00% |
GRIMES & COMPANY, INC. | 99,744 | $96,000 | 0.00% |